Carregant...

Genetic modification of human T lymphocytes for the treatment of hematologic malignancies

Modern chemotherapy regimens and supportive care have produced remarkable improvements in the overall survival of patients with hematologic malignancies. However, the development of targeted small molecules, monoclonal antibodies, and biological therapies that demonstrate greater efficacy and lower...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hoyos, Valentina, Savoldo, Barbara, Dotti, Gianpietro
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3487433/
https://ncbi.nlm.nih.gov/pubmed/22929977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.064303
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!